Everolimus-associated alveolar hemorrage relapse after drug discontinuation in a kidney transplant recipient

J Nephrol. 2022 May;35(4):1275-1278. doi: 10.1007/s40620-022-01298-w. Epub 2022 Mar 14.
No abstract available

Keywords: Everolimus; Kidney; Lung; Toxicity; Transplant.

MeSH terms

  • Everolimus* / adverse effects
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Kidney Transplantation* / adverse effects
  • Recurrence
  • Transplant Recipients

Substances

  • Immunosuppressive Agents
  • Everolimus